Abstract:Spherical crystallization is widely employed in pharmaceutical industry to produce spherical particles that exhibit improved micrometric performances of active pharmaceutical ingredients (APIs), including particle size, morphology, flowability, and compressibility. Especially for APIs with poor powder performance and low solubility, spherical co-crystallization offers the potential to enhance both dissolution properties and tablet manufacturability by combining the API and cocrystal coformer (CCF) into a spherical particle. In this study, we aimed to enhance the physicochemical properties of carbamazepine (CBZ) and hesperetin (HPE) by synthesizing a novel cocrystal with the stoichiometric ratio of 1:1. Crystal structure of the CBZ-HPE cocrystal was determined using single crystal X-ray diffraction (SCXRD). To further improve the poor powder performances such as low flowability and compressibility resulting from the needle morphology of the cocrystals, we designed three spherical crystallization strategies: common spherical agglomeration, oil-out-induced spherical agglomeration and spherulitic growth method. The spherical particles of CBZ-HPE cocrystals were characterized by powder X-ray diffraction (PXRD), polarized light microscopy (PLM), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), thermogravimetric analysis (TGA), particle size instrumentation, and Fourier transform infrared spectroscopy (FTIR) to provide information about crystal structure, particle morphology, particle size and circularity distribution. The results revealed significant differences in particle morphology, flowability, particle size and dissolution rate among the various spherical crystallization strategies. Theoretical calculations elucidated three spherical crystallization mechanisms: spherical agglomeration (SA), oil-out-induced spherical agglomeration (OOSA) and spherulite growth (SG). This study offers both experimental and theoretical foundations for the application of different spherical crystallization techniques in the pharmaceutical industry.

Crystal Structure and Twisted Aggregates of Oxcarbazepine Form III

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

Form IV of carbamazepine.

Crystal structure determination of the antipsychotic drug of olanzapine form III.

Impact of Crystal Habit on Solubility of Ticagrelor

Virtual Screening, Structural Analysis, and Formation Thermodynamics of Carbamazepine Cocrystals

Comparison of the Four Anhydrous Polymorphs of Carbamazepine and the Crystal Structure of Form I.

From Crystalline to Amorphous Structure of Carbamazepine Regulated by Dipeptide-Based Supramolecular Gel

Crystal Morphology Prediction of Olanzapine Forms III and IV

Manipulation of Crystal Morphology of Zoxamide Based on Phase Diagram and Crystal Structure Analysis

Cocrystals of carbamazepine: Structure, mechanical properties, fluorescence properties, solubility and dissolution rate

Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder

Rational Crystal Polymorph Design of Olanzapine

Synthesis, Crystal Structure and Characterisation of Two Crystals of 5-[4′-(Bromomethyl)biphenyl-2-yl]-2-trityl-2h-tetrazole

Crystal Structures and Thermodynamic Properties of New Atypical Antipsychotic Cariprazine and Its Hydrochloride

Tuning the physicochemical properties of axitinib by crystallization: Preparation, calculation and Structure-property relationship

Sustainable preparation of spherical particles of novel carbamazepine-hesperetin cocrystal via different crystallization strategies: From mechanism to application

Crystal Structure Optimization and Gibbs Free Energy Comparison of Five Sulfathiazole Polymorphs by the Embedded Fragment QM Method at the DFT Level

Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs

Formation Thermodynamics of Carbamazepine with Benzamide, Para-Hydroxybenzamide and Isonicotinamide Cocrystals: Experimental and Theoretical Study